NYSE - Delayed Quote USD

Medtronic plc (MDT)

比較

90.11

+0.43

(+0.48%)

收市：11月6日下午4:00 [EST]

90.31

+0.20

(+0.22%)

收市後：下午7:29 [EST]

主要活動

進階圖表

Loading Chart for MDT

9/21 12:03 PM

DELL

前收市價 89.68
開市 91.86
買盤 89.05 x 800
賣出價 91.39 x 800
今日波幅 88.90 - 92.03
52 週波幅 69.32 - 92.68
成交量 6,191,169
平均成交量 5,895,262
市值 (當日) 115.575十億
Beta 值 (5 年，每月) 0.85
市盈率 (最近 12 個月) 30.34
每股盈利 (最近 12 個月) 2.97
業績公佈日 2024年11月19日
遠期股息及收益率 2.80 (3.12%)
除息日 2024年9月27日
1 年預測目標價 96.07

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

www.medtronic.com

95,000